BackRevance Therapeutics Overview

Revance Therapeutics Operating Income

Operating Income for RVNC.

Quarterly Operating Income

$-32256000.00
↓ 76.84% YoY

As of Sep 30, 2024

Annual Operating Income (TTM)

$-166000000.00
↓ 50.81% YoY

Trailing 12 months ending Sep 30, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin